• OPEN AN ACCOUNT
Indian Indices
Sensex
73,279.37 -319.30
( -0.43%)
Global Indices
Nasdaq
52,406.83 24.25
(0.05%)
Dow Jones
7,744.04 46.27
(0.60%)
Hang Seng
64,060.29 791.92
(1.25%)
Nikkei 225
10,685.39 -81.94
(-0.76%)
Forex
USD-INR
95.11 0.17
(0.18%)
EUR-INR
106.49 0.13
(0.12%)
GBP-INR
127.03 0.10
(0.08%)
JPY-INR
0.60 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
40.36
77.55
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Refex commences Ready-Mix Concrete (RMC) business
Sep 25,2026

Refex Industries has commenced its Ready-Mix Concrete (RMC) business, leveraging its existing capabilities and expertise in the Coal and Ash Handling business to expand into downstream construction materials and further strengthen its presence in the infrastructure and construction ecosystem.

The RMC business is headed by  Anil Kulkarni, Chief Business Officer.

The RMC business involves the production and supply of ready-mix concrete for residential, commercial, industrial and infrastructure projects. The Company proposes to undertake the RMC business through a lease-based, asset-light model, facilitating faster market entry and scalable expansion while enabling optimised capital deployment.

In this regard, the Company has commenced commercial operations at its first RMC plant located at Wadmukhwadi, Pune, Maharashtra, with effect from 25 September 2026.